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ABSTRACT 
BACKGROUND: The prevalence of congenital uterine anomalies in women 
with reproductive failure remains unclear, largely due to methodological bias. The 
aim of this review is to assess the diagnostic accuracy of different methodologies 
and estimate the prevalence of congenital uterine anomalies in women with 
infertility and recurrent miscarriage (RM). METHODS: Studies from 1950-2007 
were identified through a computer MEDLINE search; all relevant references 
were further reviewed. RESULTS: The most accurate diagnostic procedures are 
combined hysteroscopy and laparoscopy, sonohysterography (SHG) and possibly 
three-dimensional ultrasound (3D US). Two-dimensional ultrasound (2D US) and 
hysterosalpingography (HSG) are less accurate and are thus inadequate for 
diagnostic purposes. Preliminary studies (n=24) suggest MRI is a relatively 
sensitive tool. A critical analysis of studies suggests that the prevalence of 
congenital uterine anomalies is ~6.7% [confidence interval (CI) 95%, 6.0 – 7.4] in 
the general population, ~7.3% (CI 95%, 6.7 – 7.9) in the infertile population and 
~16.7% (CI 95%, 14.8 – 18.6) in the recurrent miscarriage (RM) population. The 
arcuate uterus is the commonest anomaly in the general and RM population. In 
contrast, the septate uterus is the commonest anomaly in the infertile population, 
suggesting a possible association. CONCLUSION: Women with RM have a high 
prevalence of congenital uterine anomalies and should be thoroughly investigated. 
HSG and/or 2D US can be used as an initial screening tool. Combined 
hysteroscopy and laparoscopy, SHG and 3D US can be used for a definitive 
diagnosis. The accuracy and practicality of magnetic resonance imaging (MRI) 
remains unclear. 
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Introduction 
Congenital uterine anomalies have been clearly implicated in women suffering 
with recurrent miscarriage (RM) (Grimbizis et al, 2001). In women with 
infertility, however, the role of these anomalies, and particularly that of the 
septate uterus, remains unclear (Homer et al, 2000; Taylor and Gomel, 2008). 
Correct assessment of the prevalence of these anomalies in the RM and infertile 
populations, and comparison to the general population, will help make any 
association more apparent. For any population group, the exact prevalence of 
congenital uterine anomalies is difficult to elucidate mainly due to three reasons: 
i. Different diagnostic procedures used; 
ii. Subjectivity of the diagnostic criteria used (Grimbizis, 2001; Woelfer, 
2001); and 
iii. Inconsistent interpretation of the classification of congenital uterine 
anomalies (Raga, 2003)  
There are a number of studies which have investigated the prevalence of 
congenital uterine anomalies in the RM, infertile and general population. 
However, they lack consistency in the characteristics of each population 
examined and homogeneity in the diagnostic methods used. Previous reviews 
(Acien, 1997; Nahum, 1998; Propst and Hill, 2000; Grimbizis et al, 2001; 
Kupesic, 2001; Troiano and McCarthy, 2004) have not taken these two factors 
into account when assessing the prevalence of these anomalies. This critical 
review attempts to determine the true prevalence of congenital uterine anomalies 
in three populations. This is achieved by assessing and taking into account the 
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accuracy of different diagnostic procedures, and considering the characteristics of 
different patient groups.  
Methods 
Literature search 
Articles were identified through a computer MEDLINE search (1950-2007). 
References of all relevant articles were hand-searched for additional citations. 
There were no language restrictions. 
 
Accuracy of diagnostic procedures 
a. Identification of the presence of congenital uterine anomalies 
Studies comparing the diagnostic accuracy of different procedures used for 
assessing congenital uterine anomalies were identified. From these, the studies 
comparing hysterosalpingography (HSG), sonohysterography (SHG), 2D 
ultrasound (2D US), 3 D ultrasound (3D US) and magnetic resonance imaging 
(MRI) to hysteroscopy were selected for analysis. This is because hysteroscopy 
allows for the direct visualization of the internal uterine contour, and was 
considered the most valid method of identifying the presence of an anomaly (but 
not the different subtypes). Sensitivity, specificity, positive predictive value 
(PPV) and negative predictive value (NPV) for each diagnostic procedure were 
individually calculated for each study. The value of total correct predictions 
(accuracy), which is dependent on the prevalence and is of more clinical 
significance (Altman, 1993), was also estimated using the formula: 
 
Accuracy = 
 
NegativesTrueNegativesFalsePositivesFalsePositivesTrueofnumbers
NegativesTrueofnumberPositivesTrueofnumber


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Finally, the weighted mean values of sensitivity, specificity, PPV, NPV and 
accuracy were estimated for each procedure from all the studies.  
 
b. Identification of congenital uterine anomaly subtypes 
Studies assessing the accuracy of different procedures in diagnosing specific 
subtypes of congenital uterine anomalies were similarly reviewed. These reports 
compared the findings of each methodology to a definitive diagnosis made by 
means of visualization of both the internal and external uterine contour (e.g. 
hysteroscopy and laparoscopy). 
 
Classification of diagnostic procedures 
Following analysis, the diagnostic procedures were ranked into three 
classes (I – III) according to their diagnostic accuracy: 
Class I 
Ia. Investigations capable of accurately identifying congenital uterine 
anomalies and classifying them into appropriate subtypes (accuracy 
>90%). 
Ib. Investigations capable of correctly identifying congenital uterine 
anomalies (accuracy >90%) without being able to classify them into 
appropriate subtypes. 
Class II 
Investigations capable of identifying congenital uterine anomalies with 
accuracy <90%. 
Class III 
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Investigations of which the accuracy in identifying congenital uterine 
anomalies is uncertain. 
 
 
Assessing the prevalence of congenital uterine anomalies 
Studies assessing the prevalence of congenital uterine anomalies in three different 
populations: general/fertile, infertile and recurrent miscarriage, were identified. 
Studies were excluded when the population examined or the diagnostic methods 
used, were not accurately defined. Studies were then grouped into three classes (I 
– III), as described above, according to the diagnostic procedures they used. The 
mean overall and subtype prevalence of congenital uterine anomalies (for each 
population group) were then estimated from each class of study. 
 
Uterine development 
Embryology 
The uterus is formed at around 8-16 weeks of foetal life from the development of 
the two paired paramesonephric ducts, called Müllerian ducts. The process 
involves three main stages (Letterie, 1998; Braun et al, 2005): 
i. Organogenesis: The development of both Müllerian  ducts. 
ii. Fusion: The lower Müllerian ducts fuse to form the upper vagina, cervix 
and uterus; this is termed lateral fusion. The upper cranial part of the 
Müllerian ducts will remain unfused and form the Fallopian tubes. 
iii. Septal absorption: After the lower Müllerian ducts fuse, a central septum 
is left which starts to resorb at approximately 9 weeks eventually leaving a 
single uterine cavity and cervix. 
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It is also important to note the role of the mesonephric (or Wolffian) ducts. These 
are a precursor and inducer of female reproductive tract development, and play a 
crucial role in renal development (Hannema and Hughes, 2007). In addition, they 
act with the Müllerian tubercle to form part of the vagina. As a result, 
abnormalities originating from mesonephric maldevelopment may also have an 
effect on genital tract and uterine formation (Acien et al, 2004).  
This is reflected in the fact that up to 60% of women with unilateral renal 
agenesis have been shown to have genital anomalies (Barakat, 2002), most 
commonly a unicornuate uterus (Troiano, 2004). Interestingly, approximately 
40% of all patients with a unicornuate uterus suffer from renal abnormalities 
(Fedele et al, 1996), while one study showed that more than 80% of patients with 
a uterus didelphys suffered from renal agenesis (Li et al, 2000). Consequently, the 
detection of a congenital renal abnormality should alert the physician to look for 
associated genital anomalies and vice versa (Oppelt et al, 2007).  
 
Genetics 
The role of genetic factors in the development of uterine anomalies remains 
unclear (Kobayashi and Behringer, 2003). A study of 1397 cases by Hammoud et 
al (2008) showed that there is strong evidence for familiality contributing to 
congenital uterine anomalies, with first-degree relatives having a 12-fold risk of 
developing an abnormality. However, a specific genetic aetiology for each type of 
anomaly was considered unlikely, as members of the same family had different 
phenotypic expressions of uterine anomalies. The authors concluded that in 
addition to genetic predisposition, socioeconomic and geographic factors may 
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also play a role, as the pattern of familial clustering was shown to be consistent 
with polygenetic/multifactorial disorders. 
Interestingly, Rabinson et al (2006) in a study of 24 women with uterine 
anomalies, found that 22.7% had an undiagnosed sensorineural hearing loss (200-
fold higher rate than expected). Similar findings have been previously reported in 
the literature (Letterie and Vauss, 2001). Although the authors of this study were 
unable to identify a possible mutation contributing to this association, they 
suggested routine referral of all patients with congenital uterine anomalies for 
audiometric testing (Rabinson et al, 2006). 
Nevertheless, there has been recent progress in understanding certain 
genetic processes that underlie genital tract development (Kobayashi and 
Behringer, 2003; Hannema and Hughes, 2007). Several genes, such as Pax2 
(paired box gene 2), Pax8 (paired box gene 8), Lim1 (LIM homeobox 1) and 
Emx2 (empty spiracles homeobox 2), have been implicated in the development of 
the Wolffian and Müllerian ducts, although most data has been derived from 
mouse knockout studies (Hannema and Hughes, 2007). In addition, genes 
responsible for certain human syndromes that also affect the reproductive tract 
have been identified. Examples include Maturity-onset diabetes of the young type 
V (TCF2 mutation), McKusick-Kaufman syndrome (MKKS mutation), Persistent 
Mullerian duct syndrome type I and II (MIS and MISR2 mutations) and Hand-
foot-genital syndrome (HOXA13 mutation) (Kobayashi and Behringer, 2003).  
 
Classification of congenital uterine anomalies 
Congenital uterine anomalies may arise from malformations at any step of the 
Müllerian  developmental process (Devi Wold, 2006). Buttram and Gibbons 
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(1979) first proposed a classification of the congenital uterine anomalies based on 
the degree of failure of the Müllerian  ducts to develop normally, and divided 
them into groups with similar clinical manifestations, treatments and prognosis. 
This was revised and modified first in 1983 and then in 1988 by the American 
Society of Reproductive Medicine (formerly known as the American Fertility 
Society) to provide a classification which is now the most widely accepted and 
used worldwide (Figure I) (Letterie, 1998). This consists of seven groups, some 
with further subdivisions (Devi Wold, 2006): 
I. Müllerian  agenesis or hypoplasia 
a. Vaginal 
b. Cervical 
c. Fundal 
d. Tubal 
e. Combined 
II. Unicornuate uterus (agenesis or hypoplasia of one of the two Müllerian  
ducts) 
a. With a communicating rudimentary horn 
b. With a non-communicating rudimentary horn 
c. With a rudimentary horn with no cavity 
d. With an absent rudimentary horn 
III. Didelphys uterus (failure of lateral fusion of the vagina and uterus Müllerian  
ducts) 
IV. Bicornuate uterus (incomplete fusion of the uterine horns at the level of the 
fundus) 
a. Complete 
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b. Partial 
V. Septate uterus (absent or incomplete resorption of the uterovaginal septum) 
a. Complete 
b. Partial 
VI. Arcuate uterus (a mild indentation at the level of the fundus from a near-
complete resorption of the uterovaginal septum) 
VII. Diethylstilbestrol (DES) exposed uterus (T-shaped uterus resulting from 
DES exposure of the patient in utero) 
Figure I: Classification of congenital uterine anomalies as described by the American 
Fertility society (1988) 
 
One limitation of this classification is that it does not specify the diagnostic 
methods or criteria that should be used in order diagnose the anomalies and as a 
result this is solely based on the subjective impression of the clinician performing 
the test (Woelfer, 2001). 
In addition, this classification is by no means comprehensive. A number of 
rarer anomalies, such as a hypoplastic non-cavitated uterus with two rudimentary 
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horns (Sadik et al, 2002), a uterus with a vaginal anastomosis and cervical atresia 
(Deffrages et al, 2001), a septate uterus with cervical duplication and a 
longitudinal vaginal septum (Wai et al, 2001; Pavone et al 2006) and a normal 
uterus with a double cervix and vagina, and a blind cervical pouch (Dunn and 
Hantes, 2004) are not included. For this reason, the American Fertility Society 
classification system should function as a framework for the description of 
anomalies, rather than an exhaustive list of all possible anomaly types. 
Consequently, clinicians faced with complex or combined uterine anomalies, 
should try to describe them according to their component parts rather than 
categorize them into the class that most approximates the dominant feature 
(Troiano, 2004).  
The above concept has been incorporated in another more recent 
classification proposed by Oppelt et al (2005): the VCUAM classification. This 
intends to make the description of complex genital anomalies easier by 
subdividing external and internal female genital organs into the following 
subgroups: vagina (V), cervix (C), uterus (U), adnexa (A) and associated 
malformations (M). An anomaly is therefore graded individually for each 
anatomical structure. For example, a particular case of uterus didelphys could be 
described as: V2b (complete septate vagina), C1 (duplex cervix), U2 (bicornate 
uterus), A0 (normal adnexa), M0 (no associated malformations) (Oppelt et al, 
2005). 
Finally, Acien et al (2004) have stressed the importance of considering the 
embryological origin of the different elements of the genitourinary tract in order 
to understand and effectively treat complex genital tract anomalies. For this 
reason, they proposed the revised „Clinical and embryological classification of the 
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malformations of the female genital tract‟, which classifies anomalies according 
to their embryological origin, and includes changes in the vagina, adnexa, and 
renal system in addition to those of the uterus, (Acien et al, 2004). 
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Diagnostic procedures: characteristics and accuracy 
Hysterosalpingography 
Hysterosalpingography (HSG), first performed by Rindfleisch in 1910 (Golan, 
1989), is a widely acceptable and available diagnostic tool. It provides valuable 
information regarding the interior cavity of the uterus. When it shows a 
unicornuate uterus, however, a second cervical opening must be considered; if it 
is found, further injection of contrast into the cervix may lead to the diagnosis of a 
uterine didelphys or a complete septate uterus (Letterie, 1998). In assessing a 
unicornuate uterus with HSG, blocked or non-communicating rudimentary horns 
will not appear on film (Propst and Hill, 2000). This is of significance as studies 
have reported that in patients with such anomaly, 13% of pregnancies occur in the 
non-communicating rudimentary horn, secondary to transmigration of sperm 
(Letterie, 1998). As this would warrant removal of the rudimentary horn due to 
possible rupture, it is of great importance that non-communicating rudimentary 
horns are correctly identified and differentiated. By removing rudimentary horns, 
dysmenorrhoea and endometriosis (caused by retrograde menstrual effluent) may 
also be reduced or prevented (Taylor and Gomel, 2008). Transabdominal 
ultrasound has demonstrated 85% sensitivity and 100% specificity in diagnosing 
the presence of a rudimentary horn, and 80% sensitivity and 100% specificity in 
assessing the presence of a cavity in that horn. This was shown to be more 
accurate than a laparoscopic investigation (Litterie, 1998). In cases where clear 
ultrasound imaging is not achieved, MRI could be of use.  
HSG does not evaluate the external contour of the uterus and therefore it 
cannot reliably differentiate between a septate and a bicornuate uterus (Kupesic, 
2001; Troiano and McCarthy, 2004; Braun, 2005). Some authors suggest that an 
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angle of less than 75
o 
between the uterine horns is suggestive of a septate uterus 
and an angle of more than 105
o
 indicates a bicornuate uterus (Litterie, 1998; 
Troiano and McCarthy, 2004). Interestingly, an angle of less than 60
o
 has been 
used for identifying septate uteri in MRI and US imaging (Litterie, 1998). 
However, a diagnostic accuracy of 55% in differentiating between the two has 
been reported in the past (Reuter et al, 1989), although the criteria used in this 
study are not known. Small septal defects can also be missed with HSG (Homer et 
al, 2000). In contrast, it has been considered accurate in diagnosing most DES-
linked uterine anomalies (Nguyen, 1997). 
HSG has been reported to produce pain in more than half the patients, 
although often not severe enough to require analgesia (Homer et al, 2000). 
Guilmares Filho et al (2006) reported that 93.3% (n=56) of women experienced 
moderate to severe pain during HSG although they did not mention whether 
analgesia was required. In contrast, Tur-Kaspa et al (1998) in a prospective 
randomized blinded study of 61 patients, found that from a pain scale of 0-10 (10 
being very severe pain) women scored the HSG as being 5.6± 2 when a metal 
cannula was used and 3.8± 2 when a balloon catheter was used. The difference 
reached statistical significance, and the authors concluded that balloon catheter 
HSG is superior to the traditional metal cannula technique, as it also requires 
significantly less fluoroscopic time, a smaller amount of contrast agent, is easier 
for the physician to perform and allows for concurrent transcervical tubal 
catheterization (Tur-Kaspa et al, 1998). 
 Complications of HSG include pelvic inflammatory disease, particularly 
if the patient has previous tubal disease or is Chlamydia trachomatis positive 
(Homer et al, 2000). Bleeding, and rarely reaction to the contrast media or uterine 
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perforation may also occur(Simpson, 2006). In addition, there is exposure to 
radiation and iodinated contrast media, although this has been shown to be within 
the safety limits (Litterie, 1998; Homer, 2000). 
There have been a number of reports assessing the diagnostic accuracy of 
HSG versus hysteroscopy. A summary of the reports is shown in Table I. 
Although the weighted mean of sensitivity and specificity of HSG 
according to our review is approximately 78% and 90% respectively, this 
investigation seems to be poor in differentiating between classes of congenital 
anomalies. Alborzi et al (2003) reported only 25% sensitivity in diagnosing 
bicornuate uteri. Furthermore, Pellerito et al (1992), in an attempt to categorize 
congenital abnormalities into different types, found HSG to be incorrect in all 20 
cases. 
In conclusion, HSG remains a useful screening tool for the diagnosis of a 
normal or abnormal uterine cavity (Letterie, 1998). It has a good sensitivity for 
diagnosing uterine malformations with a more aggressive morphological 
expression (Soares et al, 2000); however, it cannot reliably differentiate between 
different types of congenital uterine anomalies. 
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Table I: Sensitivity, specificity, positive predictive value (PPV) and negative predictive 
value (NPV) of HSG compared with hysteroscopy in diagnosing congenital uterine 
anomalies (Total cases n = 625) 
Study Cases n Sensitivity Specificity PPV NPV Accuracy 
Alatas et al, 
1997 
62 100 100 100 100 100 
Brown et al, 
2000 
46 100 100 100 100 100 
Traina et al, 
2004 
80 100 97 85 100 96 
Valenzano et al, 
2006 
54 91 100 100 94 96 
Keltz et al, 
1997 
18 90 20 53 67 58 
Raziel et al, 
1994 
60 74 59 62 72 67 
Alborzi et al, 
2003 
186 70 92 83 88 83 
Guilmares Filho 
et al, 2006 
54 63 98 83 94 85 
Soares et al, 
2000 
65 44 96 67 92 75 
Weighted mean  78 90 83 91 86 
 
Two-dimensional ultrasound (2D US) 
Transabdominal or transvaginal US is a readily available diagnostic tool which is 
widely accepted and used. In assessing the presence of congenital uterine 
anomalies it may play a useful role. The advantage of US is that it allows 
measurements and quantification of observations to be made. However, there are 
no universally accepted criteria for the US diagnosis of congenital uterine 
anomalies. Different authors appeared to implement their own criteria. In a double 
cavity appearance of a uterus on US, Fedele et al (1989) and Troiano and 
McCarthy (2004) consider a uterus to be septate rather than double (i.e. 
bicornuate or didelphys) when there is a fundal distal border indentation of 5mm 
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above the line joining the two ostia (interostial line) or less. In contrast, Wu et al 
(1997), Litterie (1998) and Woelfer et al (2001) consider the uterus to be septate 
when the fundal indentation is less than 10mm below the interostial line. There 
have also been quotes of a threshold of 10mm of fundal indentation used in 
laparoscopy (Troiano and McCarthy, 2004). The use of an angle of less than 60
o
 
between the two indenting medial margins of the fundus can similarly be used to 
distinguish between the septate and bicornuate uterus. Nicolini et al (1987) 
reported that using these criteria, 92% sensitivity and 100% specificity in 
diagnosing bicornuate uteri can be achieved (Nicolini et al, 1987). However, the 
value of these criteria remains unclear. The measurement of the serosal-
endometrial thickness of the uterus along its fundal border in longitudinal sections 
could also be used as a criterion to aid diagnosis; in the septate uterus the 
thickness should increase reaching the midline as the septate becomes apparent 
(Litterie, 1998). However, there is no evidence in the literature of such criteria 
which describe the septate uterus and differentiate it from the arcuate deformity. 
Pooled data from reports comparing 2D US and hysteroscopy suggest low 
sensitivities of under 60% but high specificities of nearly 100%. Results from 
these studies are summarized in Table II.  
Although some authors in the past have quoted an accuracy of 90-92% in 
diagnosing congenital uterine anomalies (Byrne, 2000; Troiano and McCarthy, 
2004), we failed to find valid reports (comparing 2D US to hysteroscopy) 
showing sensitivities of more than 90%. There seems to be a pattern of low 
sensitivities coupled with high specificities with 2D US imaging. This suggests 
that although 2D US can only identify about half of the congenital uterine 
anomalies present, its diagnosis is very likely to be correct (due to its very low 
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false positive rate). Therefore, it could prove to be a very effective screening tool 
in conjunction with HSG since they are both widely available. 
 
Table II: Sensitivity, specificity, positive predictive value (PPV) and negative predictive 
value (NPV) of 2D US compared with hysteroscopy in diagnosing congenital uterine 
anomalies (Total cases n = 350) 
Study
1
 Cases n Sensitivity Specificity PPV NPV Accuracy 
Valenzano  
et al, 2006 
54 86 100 100 91 94 
Alatas et al, 
1997 
62 50 100 100 97 87 
Nicolini et al, 
1987 
89 43 98 94 68 76 
Traina et al, 
2004 
80 64 99 88 94 86 
Soares et al, 
2000 
65 44 100 100 92 84 
Weighted mean  56 99 96 87 84 
1
Studies by Raga et al (1996) and Jurkovic et al (1995) are not included due to 
inadequate diagnostic method of comparison used. 
 
Sonohysterography 
Sonohysterography (SHG) is also known as hysterosonography or saline-infused 
sonography (Devi Wold, 2006). It uses the introduction of fluid into the uterine 
cavity to enhance US imaging studies. It therefore improves the internal 
delineation of the uterine contour. It is a safe procedure (Hamlton, 1998) and not 
particularly painful for the patient (Amborzi, 2003). Guilmares Filho (2006) 
reported that 21.7% (n=13) women undergoing SHG experienced some degree of 
pain, which was however significantly reduced compared to HSG or 
hysteroscopy. Kelekci et al (2005) also reported significantly lower pain scores 
for SHG compared to hysteroscopy (4.3/10 vs 7.2/10; p=0.042).  
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Reports comparing SHG with hysteroscopy have suggested that SHG is 
highly accurate in both diagnosing and categorizing congenital uterine anomalies. 
The weighted mean sensitivity and specificity was 93% and 99% respectively. A 
summary of the reports reviewed are shown in Table III. 
It appears that SHG is a safe procedure which provides more information 
about uterine abnormalities than HSG or US alone (Devi Wold, 2006). It seems to 
be accurate not only in diagnosing congenital uterine anomalies, but also in 
classifying them into appropriate groups (Ventolini, 2004; Valenzano, 2006). 
 
Table III: Sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV) of SHG compared with hysteroscopy in diagnosing congenital 
uterine anomalies (Total cases n = 486) 
Study Cases 
n 
Sensitivity Specificity PPV NPV Accuracy 
Alatas et al, 
1997 
62 100 100 100 100 100 
Brown et al, 
2000 
46 100 100 100 100 100 
Keltz et al, 1997 18 100 100 100 100 100 
Valenzano et al, 
2006 
54 100 100 100 100 100 
Guilmares Filho 
et al, 2006 
55 100 94 73 100 92 
Alborzi et al, 
2003 
186 91 100 100 96 97 
Soares et al, 
2000 
65 73 100 100 97 93 
Weighted mean  93 99 97 98 97 
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Three-dimensional ultrasound (3D US) 
As in the case of 2D US, 3D US is a non-invasive method of investigation. 3D US 
works by attaining an initial 2D US image of the uterus and storing it onto a 
computer. A vaginal transducer then performs a sweep of transversal sections 
which are also subsequently stored. The computer then integrates the images and 
allows the investigator to view images of three planes simultaneously (Raga, 
1996). This 3D image, along with the complete volume scan, can be stored for 
later viewing and appraisal (Devi Wold, 2006). As discussed above, both 2D and 
3D US allow for the uterine dimensions to be measured, which could help in 
quantifying the morphological defects (Salim, 2004). The introduction of 
appropriate criteria could improve the homogeneity of diagnoses in the future. A 
study by Salim et al (2003b) evaluated the interobserver variability of 83 US 
volumes using two different observers, who were blind to each other‟s findings. 
The results showed a 99% agreement between the two observers, suggesting that 
this investigation is highly reproducible. 
Unfortunately there have not been many reports comparing the accuracy 
of 3D US to hysteroscopy and or laparoscopy. Four reports identified in the 
literature, containing an overall of 679 subjects, all reported 100% sensitivity, 
specificity, PPV, NPV and accuracy of 3D US in diagnosing congenital uterine 
anomalies, when compared with hysteroscopy (Wu et al, 1997; Radoncic et al, 
2000; Makris et al, 2007a; Makris et al, 2007b). However, in the studies by 
Makris et al (2007a, 2007b), only a small number of congenital uterine anomalies 
were identified in the groups of women screened, Two other studies were 
excluded as their method of comparison were investigations other than 
hysteroscopy (Jurkovic et al, 1995; Raga et al, 1996). 
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In conclusion, reports suggest that 3D US has a very high accuracy rate in 
diagnosing congenital uterine anomalies. Wu et al (1997) further showed that it is 
accurate in classifying the anomalies, although further studies are required to 
confirm this. With the prospect of an introduction of a classification based on 3D 
US criteria, this method seems promising. 
 
Hysteroscopy 
Hysteroscopy allows direct visualisation of the intrauterine cavity and ostia. It 
is therefore very accurate in identifying congenital uterine anomalies and is often 
used to establish a definitive diagnosis after an abnormal HSG finding (Letterie, 
1998; Soares et al, 2000; Homer et al, 2000). However, it does not allow for the 
evaluation of the external contour of the uterus and is therefore often inadequate 
in differentiating between different anomaly types. Consequently, for the correct 
differentiation between bicornuate and septate uteri, further investigation is 
required, most commonly a diagnostic laparoscopy. Some authors consider this 
combination (hysteroscopy/laparoscopy) to be the gold standard in evaluating 
congenital uterine anomalies (Hamilton et al, 1998; Litterie, 1998; Homer et al, 
2000; Grimbizis et al, 2001; Taylor and Gomel, 2008). However, it can still be 
criticized for relying solely on the subjective impression of the clinician and not 
on strict diagnostic criteria (Woelfer, 2001). Hysteroscopy with laparoscopy 
offers the added advantage of concurrent treatment, as in the case of a uterine 
septum resection.  
Bettochi et al (2007) recently proposed a new method for differentiating 
between a septate and bicornuate uterus with the use of office hysteroscopy alone, 
in a procedure that may also be performed without the use of anaesthesia or 
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analgesia. Three criteria were used while assessing 260 patients with a double 
uterine cavity: the presence of vascularized tissue, sensitivity of the tissue based 
on its innervation, and its appearance at incision (if suspected to be a septum). In 
this series, 93.1% of the patients went on to successfully undergo an office 
hysteroscopic metroplasty during this procedure. In 15 of 18 (83%) patients who 
underwent laparoscopy, the diagnosis of a suspected bicornuate uterus was 
confirmed. 
Ultimately, the main disadvantage of hysteroscopy is the invasiveness of the 
procedure which in the past was usually performed under general anaesthetic. 
Nowadays, hysteroscopy is often performed under local anaesthetic. 
Complications are similar to HSG although rarely air emboli or uterine 
perforation may also occur (Kupesic, 2001). 
 
Magnetic resonance imaging (MRI) 
MRI offers a non-invasive approach of assessing the internal and external contour 
of the uterus. Criteria used to distinguished bicornuate from septate uteri are often 
similar to those used in US: a 10mm threshold of fundal indentation, an 
intracornual distance of more than 4cm or an angle between the two indenting 
medial margins of the fundus of more than 60
o
 (Litterie, 1998). Pellerito et al 
(1992) reported 100% accuracy (n = 24) in assessing women with a surgically 
proven uterine anomaly; results were compared to hysteroscopy and laparoscopy. 
Fedele et al (1989) reported 100% sensitivity (n = 4) and 79% specificity (11/14) 
in diagnosing congenital uterine anomalies; however their results were compared 
to HSG and laparoscopy.  
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MRI seems a relatively sensitive tool and some authors suggest that it 
could supplant invasive procedures such as laparoscopy for the diagnosis of a 
double uterus (Nguyen, 1997). However, due to the lack of evidence more studies 
are required to confirm its diagnostic accuracy. 
 
Which method to use 
Overall, hysteroscopy and laparoscopy, SHG and 3D US are the most accurate 
investigations and can be used as diagnostic tools. 3D US offers the advantage of 
being non invasive. SHG requires the introduction of fluid into the uterine cavity 
and this can often be uncomfortable. Hysteroscopy and laparoscopy are both 
invasive procedures; however they offer the advantage of concurrent diagnosis 
and treatment. Hysteroscopy alone can identify the presence of an anomaly but 
cannot accurately differentiate between the different subtypes.  
2D US is the least accurate method of investigation; however it is the most 
widely available and easiest to perform. If used in conjunction with HSG, it can 
increase accuracy and serve as a valuable screening tool, particularly in the 
absence of 3D US, or where SHG is not practiced. MRI seems to be more 
accurate than 2D US or HSG alone, and could potentially be used for screening. 
However, its diagnostic accuracy remains unclear. Disadvantages are that it is 
more expensive than US and HSG, and is not available in the office setting. 
A summary and classification of the procedures reviewed according to 
their diagnostic accuracy is presented in Table IV. 
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Table IV: Classification of investigations according to diagnostic accuracy 
Class Ia 
Investigations capable of accurately identifying congenital uterine 
anomalies and classifying them into appropriate subtypes (accuracy > 
90%): 
1. Hysteroscopy and laparoscopy 
2. SHG 
3. 3D US 
Class Ib 
Investigations capable of accurately identifying congenital uterine 
anomalies (accuracy > 90%) without being able to classify them into 
appropriate subtypes: 
1. Hysteroscopy alone 
Class II 
Investigations capable of identifying congenital uterine anomalies with an 
accuracy < 90%: 
1. HSG 
2. 2D US 
Class III 
Investigations of which the accuracy in diagnosing congenital uterine 
anomalies is uncertain: 
1. MRI 
2. Physical examination during pregnancy or delivery 
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Prevalence 
In assessing the prevalence of congenital uterine anomalies, investigators have 
used different diagnostic methods, some of which may be more accurate than 
others. In this aggregate analysis we grouped the studies into three classes (as 
shown in Table IV) according to the diagnostic accuracy of the methods they 
used: i.e. class Ia studies used hysteroscopy/laparoscopy, SHG or 3D US; class Ib 
studies used hysteroscopy alone; class II studies used HSG or 2D US; and class 
III studies used a methodology of uncertain accuracy. The prevalence was then 
estimated for each class of studies. 
 
General population 
Assessing the prevalence of congenital uterine anomalies in the general 
population poses added difficulties. Many congenital uterine anomalies remain 
asymptomatic and investigations such as HSG, hysteroscopy and laparoscopy 
would not be warranted in women without a particular indication. The studies 
reviewed in this paper include patients either undergoing sterilization or being 
investigated for non-obstetric reasons such as pelvic pain, ovarian cancer 
screening, abnormal bleeding and suspected fibroids (Woelfer et al, 2001). 
Consequently the results are indicative of the fertile and general population 
combined. However, it has to be noted that the varying presentation of the 
patients and their different background/origin may have an effect on the 
homogeneity of the results. A summary of the studies reviewed is shown in Table 
V. The pooled prevalence estimated using these studies is summarized in Table 
VI. 
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According to our evaluation of the literature, the prevalence of congenital 
uterine anomalies in the fertile/general population based on class Ia and Ib studies 
is approximately 6.7% (CI 95%, 6.0 – 7.4). This is higher than what is most 
commonly quoted in the literature (Grimbizis et al, 2001; Troina, 2004; Nauhum, 
2006). Class II investigations seem to indicate a pooled prevalence of 2.4%, 
suggesting under-diagnosis. The 60-80% sensitivity of these class II 
investigations could have contributed to the finding of this lower prevalence.  
The commonest congenital uterine anomaly diagnosed in both class I and 
class II investigations seems to be that of the arcuate uterus. This is different to 
the finding of other reviews which considered the septate uterus to be the 
commonest (Grimbizis et al, 2001; Troiano and McCarthy, 2004; Tayor and 
Gomel, 2008). According to the findings of this review the commonest anomalies 
follow the order of arcuate, septate and bicornuate at a ratio of approximately 
17:7:1 (based on class Ia studies). It is interesting to note that this seems to follow 
the inverse sequence of the embryological events that occur during uterine 
formation. A unicornuate uterus was noted in only one of the three class Ia studies 
(Salim et al, 2003) thus indicating a prevalence of approximately 1 in 4000 
women. In contrast, class II studies suggested a prevalence of 1 in 1000 women. 
Keeping in mind that 3 of the 5 class II studies (Raga, 1997; Acien, 1997; 
Sorensen, 1988) used HSG with laparoscopy (an accurate way of diagnosing 
unicornuate uteri), the rate of 1 in 1000 may be closer to the true prevalence. This 
may suggest that 3D US (which comprised 3 of 4 class Ia studies reviewed) is not 
so sensitive in identifying unicornuate uteri. It could be that the single cavity of 
the unicornuate uterus is misleading when seen on US and is confused with a 
normal single uterine cavity. Similarly the transvaginal 2D US used as an initial 
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screening method by Salim et al (2003) could have the same limitation. In 
addition, the use of 2D US as a screening tool could have led to an overall under-
diagnosis of all congenital uterine anomalies in that study (as this investigation 
has shown to be approximately 60% sensitive). HSG should not have the 
limitation of under-diagnosing unicornuate uteri as the Fallopian tubes would be 
depicted on X-ray, unless a blocked tube is present. Similarly the tubal ostia 
should be visualized by hysteroscopy.
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Table V: Prevalence of congenital uterine anomalies in the general/fertile population (US=ultrasound; TVS=transvaginal ultrasound; TAS=transabdominal ultrasound; 
HSG=hysterosalpingography; SHG=sonohysterography; HSc=hysteroscopy; Lap=laparoscopy/Laparotomy) 
 
Class Study Country Cases 
n 
Reason for 
investigation 
Initial 
Investigatio
n 
Definitive 
Investigation 
Total 
n (%) 
Hypoplastic 
n (%) 
Unicornuate 
n (%) 
Didelphys 
n (%) 
Bicornuate 
n (%) 
Septate 
n (%) 
Arcuate 
n (%) 
T-shaped 
n (%) 
 
 
 
Ia 
Salim et al, 20031 UK 1976 Not stated 2D TVS 3D US 105 (5.3) - 1 (0.05) - 4 (0.2) 28 (1.4) 72 (3.6) - 
Woelfer et al, 20011 UK 1089 Non-obstetric - 3D TVS 106 (9.7) - - - 5 (0.5) 29 (2.7) 72 (6.6) - 
Jurkovic et al, 1997 UK 1047 Various - 3D US 55 (5.3)        
Tur-Kaspa et al, 2006 Canada/
USA 
409 Abnormal 
uterine bleeding 
- SHG 39 (9.5) - - 1 (0.2) 1 (0.2) 11 (2.7) 26 (6.4)  
Ib Cooper et al, 1983 - 323 Hysteroscopic 
sterilization 
- HSc 20 (6.2)        
 
 
 
 
 
 
 
II 
Byrne et al, 2000 USA 2065 Non-obstetric - TAS/TVS 8 (0.4) - - 3 (0.1) 3 (0.1) 2 (0.1) - - 
Raga et al, 1997  Spain 1289 Tubal 
sterilization 
 
- 
HSG/Lap 49 (3.8) - 2 (0.2) 1 (0.1) 5 (0.4) 20 (1.5) 21 (1.6) - 
Simon et al, 19912 Spain 679 Tubal 
sterilization 
 
- 
HSG/Lap 22 (3.2) - - 1(0.1) 1 (0.1) 20 (2.9) - - 
Ashton et al, 19883 - 840 Transcervical 
sterilization 
- HSG 19 (2.3)  1 (0.1) - 15 (1.8) - 3 (0.4) 
Nasri et al, 1990 UK 300 Multiple - 2D TVS 8 (2.7) - - 2 (0.7) - 6 (2.0) - - 
Acien et al, 19974 Spain 241 Contraception 2D TVS HSG/Lap 26 (10.8) 5 (2.1) 1 (0.4) - 3 (1.2) 4 (1.7) 13 (5.4) - 
Sorensen, 19885 Denmark 111 Laparoscopic 
sterilization 
- HSG/Lap 6 (5.4) - 1 (0.9) 1 (0.9) - 4 (3.6) - - 
 
III 
Nahum, 1998 
[Review: 1947-1990]6 
- 571619 Pregnancy/ 
Delivery 
- Various 927 (0.16)        
1May have similar cases. 1 
2Included in the study by Raga et al (1997) and thus not included in Table VI. 2 
3Bicornuate/septate diagnosis not included in Table VI. 3 
4 HSG and laparoscopy/laparotomy was not performed in all cases detected by transvaginal US. 4 
5 Author does not consider “mild to moderate fundal excavations” a uterine structural abnormality. 5 
6Not included in Table VI. 6 
7 
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Table VI: Prevalence of congenital uterine anomalies in the general/fertile population from selected series 
 
Class  Studies
1
 
n 
Cases  
n 
Total 
n (%) 
Hypoplastic 
n (%) 
Unicornuate 
n (%) 
Didelphys 
n (%) 
Bicornuate 
n (%) 
Septate 
n (%) 
Arcuate 
n (%) 
T-shaped 
n (%) 
Ia 4 4521 305 (6.7)
 2
 - 1 (0.03) 1 (0.03) 10 (0.3) 68 (2.0) 170 (4.9) - 
Ib 1 323 20 (6.2)        
II
1 
6 4846 116 (2.4) 5 (0.1) 5 (0.1) 7 (0.1) 11 (0.3)
 3
 36 (0.9)
3
 34 (0.7) 3 (0.1) 
Total 11 9690 441 (4.6) 5 (0.1) 6 (0.1) 8 (0.1) 21 (0.3) 104 (1.3) 204 (2.4) 3 (0.03) 
1
 Summary of studies shown in Table V. 2 
2
 Jurkovic et al (1997) (n of anomalies = 55) do not provide a breakdown of the congenital uterine anomalies they diagnosed, however their data 3 
has been used to estimate the Total prevalence according to Class Ia studies. 4 
3
 Asthon et al (1988) (n of bicornuate/septate uteri = 15) do not distinguish between bicornuate and septate uteri; therefore their data has not been 5 
used for the prevalence estimates of these two subtypes. 6 
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Infertile population 1 
The role of congenital uterine anomalies in infertility remains unclear (Kupesic, 2 
2001; Grimbizis et al, 2001). However, it has been suggested that uterine 3 
anomalies may contribute to infertility , possibly by interfering with normal 4 
implantation and placentation. (Taylor and Gomel, 2008). A review by Grimbizis 5 
et al (2001) found that the overall prevalence was similar to the general 6 
population, which would suggest that there is no causal relation. Another review 7 
by Nahum (1998) found the prevalence in the infertile population to be 21 times 8 
higher than in the general population. However, in both these reviews the 9 
reliability of the diagnostic methods used by the reported studies was not 10 
considered. A summary of the studies reviewed in this paper is shown in Table 11 
VII. The pooled prevalence estimated using these studies is shown in Table VIII. 12 
According to our evaluation of the literature, the prevalence of congenital 13 
uterine anomalies in the infertile population based on class Ia and Ib studies is 14 
approximately 7.3% (CI 95%, 6.7 – 7.9). This is comparable to that found for the 15 
general/fertile population. However, class II studies show a pooled prevalence of 16 
10.8%, which is surprisingly higher. 17 
In terms of different anomalies, in both class I and class II studies the 18 
septate uterus is the commonest observed followed by the arcuate and bicornuate 19 
uteri. The ratios based on class Ia studies, are approximately 4:2:1. This is 20 
different to what was observed in the general/fertile population where the arcuate 21 
was more than twice as common as the septate uterus. Furthermore, there seems 22 
to be an increase in the prevalence of septate uteri in the infertile population 23 
compared to the general/fertile population, from 1.1% to 3.9%. This suggests a 24 
link between the septate uterus and infertility. This result is consistent with the 25 
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findings of relatively small studies that have shown that women with a septate 1 
uterus and otherwise unexplained infertility may benefit from metroplasty. 2 
However, to date there has been no published trial to randomize and compare 3 
women with treatment versus no treatment. For this reason controversy exists as 4 
to whether infertile women should undergo metroplasty (Taylor and Gomel, 5 
2008). On the other hand, as removal of the septum will potentially decrease the 6 
risk of miscarriage and preterm birth if these women are to conceive, it could be 7 
argued that metroplasty should be considered in these cases (Homer et al, 2001).   8 
In addition to the septate uterus, the prevalence of the unicornuate and 9 
hypoplastic uteri are also relatively higher in the infertile population compared to 10 
both the general/fertile and RM population, indicating an association. On the 11 
other hand, this does not seem to be the case for the arcuate uterus, which is of 12 
lower prevalence compared to the general/fertile and RM group. Interestingly, if 13 
pooled data from all studies (class I and II) is considered, the prevalence of 14 
arcuate uteri is almost identical to that of the general/fertile population (2.1 vs 15 
2.4%). This would suggest that the arcuate uterus does not have a causal role in 16 
infertility. Ultimately, the results of this review highlight the necessity for further 17 
assessment of the role of the septate uterus in infertility.18 
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Table VII: Prevalence of congenital uterine anomalies in the infertile population (US=ultrasound; TVS=transvaginal ultrasound; TAS=transabdominal ultrasound; 
HSG=hysterosalpingography; SHG=sonohysterography; HSc=hysteroscopy; Lap=laparoscopy/Laparotomy; RM= recurrent miscarriage) 
 
Class Study Country Cases 
n 
Infertility 
Description 
Initial 
Investigation 
Definitive 
Investigation 
Total 
n (%) 
Hypoplastic 
n (%) 
Unicornuate 
n (%) 
Didelphys 
n (%) 
Bicornuate 
n (%) 
Septate 
n (%) 
Arcuate 
n (%) 
T-shaped 
n (%) 
 
 
 
 
 
 
 
 
Ia 
Ugur et al, 19951 Turkey 3332 Majority of 
patients 
- PE/US/HSG/ 
HSc/Lap/ 
167 (5.0) 47 (1.4) 13 (0.4) 11 (0.3) 26 (0.3) 61 (1.8) 9 (0.3) - 
Tulandi et al, 1980 Canada 2240 - HSG HSc or Lap 23 (1.0) - 2 (0.1) 1 (0.05) 13 (0.6)  - 7 (0.3) - 
Tur-Kaspa et al, 2006 Canada/ 
USA 
600 - - TVS/SHG 120 (20) 1 (0.2) 1 (0.2) - - 28 (4.7) 90 (15.0) - 
Hamilton et al, 19982 UK 500 - - US/SHG 24 (4.8) - 1 (0.2) - 2 (0.4) 21 (4.2) - 
Radoncic et al, 2000 Croatia 267 - - 3D US/HSc  96 (36.0) - - - - 95 (35.6) 1 (0.4)  
Arbozi et al, 20033 Iran 186 Infertile/RM  Hsc/Lap 58 (31.2) - 7 (3.8) - 7 (3.8) 35 (18.8) 9 (4.8) - 
Soares et al, 2000 Brazil 65 - - SHG/HSG/ 
TVS/HSc 
9 (13.8) - 3 (4.6) - 1 (1.5) - 5 (7.7) - 
Alatas et al, 1997 Turkey 62 - - TVS/HSG/ 
SHG/HSc 
4 (6.5)        
Raga et al, 1996 Spain 42 - - HSG/Lap/ 
3D US 
12 (28.6) - 1 (2.4) 1 (2.4) 5 (12.0) 5 (12.0) - - 
Wu et al, 1997  38 - - 2D US/ HSG/3D 
US/ HSc/Lap 
25 (65.8)  4 (10.5) 2 (5.3) 3 (7.9) 11 (28.9) 5 (13.2) - 
 
Ib 
Siegler et al, 1976 USA 104 - - HSG/HSc 10 (9.6) - - - - 10 (9.6) - - 
Taylor et al, 1979 Canada 68 - - HSG/HSc 1 (1.3) - - - - 1 (1.3) - - 
 
 
 
 
II 
Raga et al, 1997  Spain 1024 >2 years - HSG/Lap 25 (2.4) - 1 (0.1) 1 (0.1) 5 (0.54) 6 (0.6) 12 (1.1) - 
Braun et al, 2005 Spain 705 - - HSG 66 (9.4) - 3 (0.4) - 9 (1.3) 16 (2.3) 38 (5.4) - 
Acien, 19974 Spain 200 - 2D TVS HSG/Lap 32 (16) 12 (6) 2 (1) 1 (0.5) 1 (0.5) 2 (1) 14 (7) - 
Nickerson et al, 19775 USA 190 Primary - HSG 93 (48.9) - 3 (1.6) - 3 (1.6) 87 (45.8) - - 
Sorensen et al, 1981 Denmark 134 - - HSG 32 (23.9) - 2 (1.5) - 7 (5.2) 23 (17.2) - 
Vasiljevic et al, 1996 Serbia 102 - - HSG/Lap 6 (5.9)        
1The number of patients investigated by either of these investigations is not mentioned. 1 
2Septate/arcuate diagnosis has not been included in Table VIII. 2 
33.8% of the cases were RM patients. 3 
4 HSG and laparoscopy/laparotomy was not performed in all cases detected by transvaginal ultrasound. 4 
5 Author includes subdivision into subseptate (n = 31; 16.3%), mildly subseptate (n = 31; 16.3%), very mildly subseptate (n = 25; 13.2%). 5 
6 
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Table VIII: Prevalence of congenital uterine anomalies in the infertile population from selected series 
Class  Studies
1
 
n 
Cases  
n 
Total 
n (%) 
Hypoplastic 
n (%) 
Unicornuate 
n (%) 
Didelphys 
n (%) 
Bicornuate 
n (%) 
Septate 
n (%) 
Arcuate 
n (%) 
T-shaped 
n (%) 
Ia 10 7332 538 (7.3)
 2
 48 (0.7) 32 (0.4) 15 (0.2) 57 (0.8) 235 (3.5)
3
 126 (1.9)
 3
 - 
Ib 2 172 11 (6.4) - - - - 11 (6.4) - - 
II
 
6 2355 254 (10.8)
4
 12 (0.1) 11 (0.5) 2 (0.1) 25 (1.1) 111 (5.2)
5
 64 (3.0)
 5
 - 
Total 18 9859 803 (8.1) 60 (0.6) 43 (0.4) 17 (0.2) 82 (0.8) 357 (3.9) 190 (2.1) - 
1
 Summary of studies shown in TableVII. 2 
2
 Alatas et al (1997) (n of anomalies = 4) do not provide a breakdown of the congenital uterine anomalies they diagnosed, however their data has 3 
been used to estimate the Total prevalence according to Class Ia studies. 4 
3
 Hamilton et al (1998) (n of septate/arcuate = 21) do not distinguish between septate and arcuate uteri; therefore their data has not been used for 5 
the prevalence estimates of these two subtypes. 6 
4
 Vasiljevic et al (1996) (n of anomalies = 6) do not provide a breakdown of the congenital uterine anomalies they diagnosed, however their data 7 
has been used to estimate the Total prevalence according to Class II studies. 8 
5
Sorensen et al (1998) (n of septate/arcuate uteri = 23) do not distinguish between septate and arcuate uteri; therefore their data has not been used 9 
for the prevalence estimates of these two subtypes. 10 
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Recurrent miscarriage population 1 
Although the association between congenital uterine anomalies and RM has been well 2 
documented (Grimbizis et al, 2001; Homer et al, 2001; Kupesic et al, 2001; Taylor 3 
and Gomel, 2008), the exact prevalence in this population has not been clearly 4 
defined. A summary of the studies reviewed in this paper is shown in Table IX. The 5 
pooled prevalence estimated using a selection of these studies is shown in Table X. 6 
According to our evaluation of the literature, the prevalence of congenital 7 
uterine anomalies in the RM population based on class Ia and Ib studies is 8 
approximately 16.7% (CI 95%, 14.8 – 18.6). Studies with ≥ 3 consecutive 9 
miscarriages were included in the analysis. However, the study by Salim et al (2003), 10 
which provides approximately 34% of the cases of class I studies, examined patients 11 
with unexplained recurrent pregnancy loss. By excluding all patients with concurrent 12 
diagnoses their findings could be exaggerated. By not including the study of Salim et 13 
al (2003) the pooled prevalence according to class I studies is reduced to 14 
approximately 13.1%. Therefore it can be assumed that the true prevalence lies 15 
approximately somewhere between 13 and 17%. Surprisingly, class II studies show a 16 
pooled prevalence of 23.3%, suggesting an over-diagnosis, rather than an under-17 
diagnosis, which would be expected from investigations of a low sensitivity (under 18 
60% for 2D US). This could be partly due to the investigators having a lower 19 
threshold for diagnosing congenital uterine anomalies in patients suffering with RM. 20 
Class I studies evaluating women with ≥ 3 non-consecutive miscarriages, 21 
show a pooled prevalence of 15.8%; this is similar to women with ≥ 3 consecutive 22 
miscarriages (16.7%). Corresponding class II studies show a prevalence of 23.3% for 23 
women with ≥ 3 consecutive miscarriages, and only 3.3% for those with ≥ 3 non-24 
consecutive miscarriages; this decrease may be partly due to the different miscarriage 25 
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pattern (consecutive vs non-consecutive), but may also be a chance finding. Class I 1 
studies of women with ≥ 2 consecutive miscarriages, show a pooled prevalence of 2 
28.3%. Corresponding class II studies show a prevalence of 13%. Both findings 3 
suggest that women presenting with only 2 miscarriages may also warrant 4 
investigations for the presence of a congenital uterine anomaly. This has been 5 
suggested by the report of Weiss et al (2005) who found no significant differences 6 
between the prevalence of congenital uterine anomalies in women with ≥ 2 versus ≥ 3 7 
miscarriages. Unfortunately, the heterogeneity of the reports does not allow for 8 
further analysis to be conducted.  9 
Regarding the different anomaly types, class Ia studies suggest that the arcuate 10 
uterus is the commonest followed by the septate and bicornuate uterus with a ratio of 11 
approximately 12:5:1. This does not vary greatly from the findings for the general 12 
population; however it is different to what is observed in the infertile population. A 13 
summary of the ratios and prevalence of different anomaly types within the three 14 
population groups is shown in Tables XI and XII respectively.  15 
The prevalence of the arcuate uterus in the RM population is 12.2%, more 16 
than 3-fold the prevalence for the general/fertile population (3.8%). This suggests a 17 
causal relation between this type of deformity and recurrent miscarriage, something 18 
which has been suggested by authors in the past (Grimbizis et al, 2001; Woelfer et al, 19 
2001). Interestingly, although the arcuate uterus could be considered a mild form of 20 
partial septate uterus (Grimbizis et al, 2001), the study by Woelfer et al (2001) 21 
suggests a different pattern of pregnancy loss in patients with arcuate versus septate 22 
uteri. Notably, their data supports the suggestion that women with arcuate uteri tend 23 
to miscarry more in the second trimester, whereas patients with septate uteri are more 24 
likely to miscarry in the first trimester. This finding could suggest a different 25 
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mechanism of miscarriage for these two uterine anomaly types. Ultimately, the 1 
impact of the arcuate uterus on the reproductive outcome should not be 2 
underestimated. 3 
Interestingly, in the current review, there are a number of class II studies that 4 
failed to identify any arcuate uteri. This could reflect the lower sensitivities of the 5 
investigations used (i.e. 2D US and HSG), which may have failed to identify the less 6 
prominent arcuate deformity. Overall, more studies are required to further clarify the 7 
prevalence of different congenital uterine anomalies within the RM population, and 8 
delineate their causal relation to RM.  9 
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1 Contains also 2 undetermined bicornuate/septate uteri. 1 
2 Data not included in Table X as subjects do not fulfil the criteria for RM. 2 
3Number or pattern of miscarriages not specified by author (assumed to be ≥ 3 consecutive as patients were attending a RM clinic). 3 
4 
Table IX: Prevalenc  of congenital uterine anomalies in the recurrent miscarriage population (US=ultrasound; TVS=transvaginal ultrasound; TAS=transabdominal 
ultrasound; HSG=hysterosalpingography; SHG=sonohysterography; HSc=hysteroscopy; Lap=laparoscopy/Laparotomy; RM= recurrent miscarriage) 
 
Class Study Country Cases 
n 
Miscarriage 
details 
Initial 
Investigation 
Definitive 
Investigation 
Total 
n (%) 
Hypoplastic 
n(%) 
Unicornuate 
n (%) 
Didelphys 
n (%) 
Bicornuate 
n (%) 
Septate 
n (%) 
Arcuate 
n (%) 
T-shaped 
n (%) 
 
 
 
 
Ia 
Salim et al, 2003 UK 509 ≥ 3 consecutive 
unexplained  
1st trimester 
2D TVS 3D US 121 (23.8) - 2 (0.4) - 6 (1.2) 27 (5.3) 86 (16.9) - 
Li et al, 2002 UK 453 ≥ 3 consecutive 2D US/ 
HSG 
HSc/Lap 49 (10.8)        
Stephenson et al, 1996 Canada 197 ≥ 3 consecutive HSG or HSc SHG or Lap 15 (7.6) - 1 (0.5) 1 (0.5) 1 (0.5) 8 (4.1) - 4 (2.0) 
 
Weiss et al, 20051 
 
 
Israel 
165 ≥ 2 consecutive2  HSc/Lap 32 (19.4)  1 (0.6) - 3 (1.8) 13 (7.9) 13 (7.9)  
98 ≥ 3 consecutive - HSc/Lap 17 (17.3)        
 
 
 
 
Ib 
 
Valli et al, 2001 
 
Italy 
344 ≥ 2 consecutive2 - HSc 112 (32.6) - 3 (0.9) - 30 (8.7) 79 (23.0) - 
141 ≥ 3 consecutive - HSc 39 (27.7) - - - - 15 (10.6) 24 (17.0) - 
Raziel et al, 19942 Israel 106 ≥ 3 - HSG/HSc 23 (21.7) - - - - 23 (21.7)  - - 
Guimaraes Filho et al, 
2006 
Brazil 60 ≥ 3 consecutive - HSc 8 (13.3)        
Tulppala et al, 19933 Finland 55 RM clinic - HSc 4 (7.3) - - - - 4 (7.3) - - 
Ventolini et al, 20042 USA 23 ≥ 3 - US/HSc 3 (13.0) - - - - 3 (13.0) - Excluded 
 
 
 
 
 
 
 
 
 
II 
Makino et al, 19922 Japan 1200 ≥ 2 - HSG 188 (15.7) - 5 (0.4) - - 50 (4.1) 133 (11.1) - 
Clifford et al, 19942 UK 500 ≥ 3 - US 9 (1.8) - - - 3 (0.6) 6 (1.2) - - 
Coulam et al, 19912 USA 214 ≥ 2 HSG HSc 1 (0.5) - - - - 1 (0.5) - - 
Stray-Pedersen, 1984 Norway 195 ≥ 3 consecutive - HSG 19 (9.7)        
Acien et al, 19983 Spain 189 RM clinic - HSG 71 (37.6)        
Harger et al, 19832 USA 155 ≥ 2 consecutive HSG HSc 17 (11.0) - 1 (0.6) - 5 (3.2) 3 (1.9) 4 (2.9) 4 (2.9) 
Coulam, 19862 USA 110 ≥ 3 - HSG 11 (9.1) - 1 (0.9) 2 (1.8) 6 (5.5) 2 (1.8) - - 
Tho et al, 19792 Georgia 100 ≥ 2 or  
≥ 1 abnormal 
conceptus 
HSG Gynae-
cography 
10 (10) - - - - 10 (10) - - 
Traina et al, 20042 Brazil 80 ≥ 2 consecutive - HSG/TVS/ 
HSc 
11 (13.6)        
Portuondo et al, 1986 Spain 40 ≥ 3 consecutive - HSG 9 (22.5) - - - - 6 (15) 3 (7.5) - 
Keltz et al, 19972 USA 34 ≥ 2 consecutive - SHG 5 (14.7) - - - 1 (2.9) 2 (5.9) - 2 (5.9) 
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 1 
Table X: Prevalence of congenital uterine anomalies in the recurrent miscarriage population (≥ 3 consecutive miscarriages) from selected series 
Class  Studies
1,  
n 
Cases  
n 
Total 
n (%) 
Hypoplastic 
n (%) 
Unicornuate 
n (%) 
Didelphys 
n (%) 
Bicornuate 
n (%) 
Septate 
n (%) 
Arcuate 
n (%) 
T-shaped 
n (%) 
Class Ia
1
 4 1257 202 (16.1)
 2
  - 3 (0.4) 1 (0.1) 7 (1.0) 35 (5.0) 86 (12.2) 4 (0.6) 
Class Ib 3 256 51 (19.9)
3
 
 
- - - - 19 (9.7) 24 (12.2) - 
Class II
 
3 424 99 (23.3)
4
 
 
- - - - 6 (15.0) 3 (7.5) - 
Total 20 1937 352 (18.2) - 3 (0.3) 1 (0.1) 7 (0.7) 60 (6.4) 113 (12.0) 4 (0.4) 
1
 Summary of studies shown in Table IX. 2 
2
 Weiss et al (2005) and Li et al (2001) (total n of anomalies = 66) do not provide a breakdown of the congenital uterine anomalies they 3 
diagnosed, however their data has been used to estimate the Total prevalence according to Class Ia studies. 4 
3
Guimaraes Filho et al, (2006) (n of anomalies = 8) do not provide a breakdown of the congenital uterine anomalies they diagnosed, however 5 
their data has been used to estimate the Total prevalence according to Class Ib studies. 6 
4
 Acien et al (1998) and Stray-Pedersen (1984) (total n of anomalies = 90) do not provide a breakdown of the congenital uterine anomalies they 7 
diagnosed, however their data has been used to estimate the Total prevalence according to Class II studies. 8 
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Table XI: Approximate ratios of uterine anomaly types in different populations
1
 
 
Population Arcuate Septate Bicornuate 
General/Fertile  17 7 1 
Infertile 2 4 1 
RM 12 5 1 
1
 Data based on class Ia studies 1 
Table XII: Congenital uterine anomalies: percentage of subtypes in different population groups.
1
 
Population 
 
Hypoplastic 
% 
Unicornuate 
% 
Didelphys 
% 
Bicornuate  
% 
Septate 
% 
Arcuate 
% 
General/fertile  
(n = 250) 
- 0.4 0.4 4.0 27.2 68.0 
Infertile  
(n = 510) 
9.4 6.1 2.9 10.8 46.1 24.7 
Recurrent Miscarriage 
(n = 132) 
- 2.3 0.8 5.3 26.5 65.2 
1
Data based only on class Ia studies using an appropriate classification of the 2 
congenital uterine anomaly types. 3 
 4 
Conclusion 5 
Based on the data derived from class Ia and Ib studies, the prevalence of 6 
congenital uterine anomalies is approximately 6.7% (CI 95%, 6.0 – 7.4) in the 7 
general/fertile population, 7.3% (CI 95%, 6.7 – 7.9) in the infertile population and 8 
16.7% (CI 95%, 14.8 – 18.6) in the RM population. The prevalence in the infertile 9 
population is similar to that of the general/fertile population. However, there 10 
seems to be a higher prevalence of septate uteri in the infertile population, 11 
suggesting an association. In addition, the high prevalence of arcuate uteri in the 12 
RM population (12.2%) highlights the potentially important role of this deformity 13 
in recurrent miscarriage, something which should not be underestimated. The 14 
relation between most congenital uterine anomalies and RM has been well 15 
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documented in the literature; furthermore, it has been suggested that treatment of 1 
certain anomalies may result in an improved pregnancy outcome (Homer et al, 2 
2000; Grimbizis et al, 2001; Kupesic, 2001; Taylor and Gomel, 2008). Therefore, 3 
any woman suffering from RM should be thoroughly investigated, to identify 4 
whether a congenital uterine anomaly is present. A number of different 5 
investigations can be used. 2D US and HSG have the lowest accuracy rates, 6 
which would not warrant use for diagnosis. However, they can be used alone or in 7 
combination as an effective screening tool. In contrast, SHG has been shown to be 8 
highly accurate in diagnosing and classifying uterine anomalies; however, it is 9 
more invasive and is not commonly practiced. Studies to date suggest that 3D US 10 
is also very accurate and can be used as a diagnostic tool; limitations include a 11 
possible underdiagnosis of unicornuate uteri and lack of availability in some 12 
centres. The accuracy and practicality of MRI has not yet been determined, 13 
however its role in screening or diagnosing congenital uterine anomalies may 14 
become more important in the future. Combined hysteroscopy and laparoscopy 15 
allows for a direct visualization of the internal and external contour of the uterus, 16 
and is therefore considered by many to be the gold standard. The main advantage 17 
is that it allows concurrent diagnosis and treatment, while the disadvantage is the 18 
invasiveness of the procedures.19 
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